Fluocinolone Acetonide/Hydroquinone/Tretinoin

氟轻松丙酮酯/氢醌/维A酸

Report date: 2026/03/16 20:01:47

Base Information

Drug NameFluocinolone Acetonide/Hydroquinone/Tretinoin
Drug Alias NameTretinoin/Fluocinolone Acetonide/Hydroquinonefluocinolone acetonide, hydroquinone, and tretinoinTri-Luma
ClassificationSmall molecules > Steroids
Mechanisms of ActionRetinoic acid receptor gamma agonistsRetinoic acid receptor alpha agonistsRetinoic acid receptor beta agonists +[5] 
TargetsTyrosinase-related protein 1Glucocorticoid receptorRetinoic acid receptor beta +[5] 
Therapy Area/IndicationsMelanosis
Global Approved IndicationsMelanosis
Approved Indications in ChinaMelanosis
Original Approved Country/TerritoryUnited States
Original Approved Date2002/01/18
Country/TerritoryUnited StatesMainland China
CombinationsYes HydroquinoneTretinoinFluocinolone Acetonide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGalderma Sa
China Registration ClassN/A

Develop Information

Active CompaniesGalderma Laboratories LpZhejiang Medicare Pharmaceutical Co Ltd
Inactive CompaniesHubei Shubang Pharmaceutical Co LtdHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Active IndicationsMelanosis
Inactive IndicationsN/A

Other Information

ATC CodeD
Related LinksN/A